Teradyne (NASDAQ:TER – Get Free Report) was downgraded by equities researchers at Craig Hallum from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday, MarketBeat Ratings reports. They currently have a $124.00 price target on the stock. Craig Hallum’s price target would suggest a potential downside of 0.27% from the stock’s previous close.
A number of other analysts also recently commented on the company. JPMorgan Chase & Co. boosted their target price on Teradyne from $120.00 to $145.00 and gave the stock a “neutral” rating in a research report on Tuesday. KeyCorp boosted their target price on Teradyne from $160.00 to $180.00 and gave the stock an “overweight” rating in a research report on Friday, July 12th. Evercore ISI initiated coverage on Teradyne in a research report on Tuesday, April 16th. They set an “outperform” rating and a $130.00 target price on the stock. UBS Group upped their price objective on Teradyne from $130.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, June 18th. Finally, The Goldman Sachs Group upped their price objective on Teradyne from $118.00 to $161.00 and gave the company a “buy” rating in a research report on Tuesday, May 28th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $142.79.
Check Out Our Latest Analysis on Teradyne
Teradyne Trading Down 13.4 %
Teradyne (NASDAQ:TER – Get Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.77 by $0.09. Teradyne had a return on equity of 19.18% and a net margin of 18.33%. The company had revenue of $729.88 million during the quarter, compared to analysts’ expectations of $701.20 million. During the same quarter in the previous year, the business earned $0.79 earnings per share. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. As a group, research analysts predict that Teradyne will post 3.06 earnings per share for the current year.
Insider Buying and Selling
In related news, Director Mercedes Johnson sold 625 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $143.84, for a total transaction of $89,900.00. Following the transaction, the director now directly owns 18,393 shares in the company, valued at $2,645,649.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Teradyne news, Director Mercedes Johnson sold 625 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $143.84, for a total transaction of $89,900.00. Following the completion of the sale, the director now directly owns 18,393 shares in the company, valued at $2,645,649.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Sanjay Mehta sold 3,750 shares of the company’s stock in a transaction dated Friday, May 3rd. The stock was sold at an average price of $120.06, for a total value of $450,225.00. Following the sale, the chief financial officer now owns 41,902 shares of the company’s stock, valued at $5,030,754.12. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,005 shares of company stock worth $1,304,763. 0.36% of the stock is owned by company insiders.
Institutional Investors Weigh In On Teradyne
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Teradyne by 0.7% during the first quarter. Vanguard Group Inc. now owns 18,421,186 shares of the company’s stock worth $2,078,462,000 after acquiring an additional 135,286 shares during the last quarter. Van ECK Associates Corp increased its stake in Teradyne by 10.4% during the first quarter. Van ECK Associates Corp now owns 4,815,017 shares of the company’s stock worth $543,278,000 after acquiring an additional 453,926 shares during the last quarter. Nordea Investment Management AB grew its stake in shares of Teradyne by 14.6% in the first quarter. Nordea Investment Management AB now owns 3,028,930 shares of the company’s stock valued at $342,178,000 after buying an additional 385,115 shares in the last quarter. Boston Partners grew its stake in shares of Teradyne by 23.2% in the fourth quarter. Boston Partners now owns 2,896,349 shares of the company’s stock valued at $314,324,000 after buying an additional 544,482 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of Teradyne by 3.3% in the first quarter. Allspring Global Investments Holdings LLC now owns 2,182,136 shares of the company’s stock valued at $246,210,000 after buying an additional 68,924 shares in the last quarter. 99.77% of the stock is currently owned by institutional investors and hedge funds.
About Teradyne
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Further Reading
- Five stocks we like better than Teradyne
- Compound Interest and Why It Matters When Investing
- Is Now the Time to Invest? ServiceNow Stock Sent to New Highs
- Learn Technical Analysis Skills to Master the Stock Market
- Leading Healthcare Provider Stock Soars on Earnings Beat
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.